Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
Gross Margin history
Percent of revenue · from the income statement
No Gross Margin data reported for this period type.
Gross Margin vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
VCREVicore Pharma Holding AB | LTM Jun 2026 | 100.0% | +17.9 pp | — |
| LTM Mar 2026 | 95.1% | -1.1 pp | +0.0 pp | |
| LTM Jun 2026 | 83.3% | +7.6 pp | +1.9 pp | |
| LTM Mar 2026 | 76.0% | +1.3 pp | +40.1 pp | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — |
| Peer median (excluding AVLN) | 89.2% | +4.4 pp | +1.9 pp | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.